These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


101 related items for PubMed ID: 4777579

  • 1. The effects of scopolamine and pilocarpine upon the aversive threshold of the rat.
    Houser VP, Van Hart DA.
    Pharmacol Biochem Behav; 1973; 1(4):427-31. PubMed ID: 4777579
    [No Abstract] [Full Text] [Related]

  • 2. The alteration of aversive thresholds with cholinergic and adrenergic agents.
    Houser VP, Houser FL.
    Pharmacol Biochem Behav; 1973; 1(4):433-44. PubMed ID: 4204777
    [No Abstract] [Full Text] [Related]

  • 3. Modulation of the aversive qualities of shock through a central inhibitory cholinergic system in the rat.
    Houser VP.
    Pharmacol Biochem Behav; 1976 May; 4(5):561-8. PubMed ID: 951435
    [Abstract] [Full Text] [Related]

  • 4. Modulation of cholinergic activity and the aversive threshold in the rat.
    Houser VP, Van Hart DA.
    Pharmacol Biochem Behav; 1974 May; 2(5):631-7. PubMed ID: 4431827
    [No Abstract] [Full Text] [Related]

  • 5. The effects of scopolamine on three different types of suppressed behavior of rats.
    McKim WA.
    Pharmacol Biochem Behav; 1980 Mar; 12(3):409-12. PubMed ID: 7393939
    [Abstract] [Full Text] [Related]

  • 6. Effect of scopolamine on the reactivity of the albino rat to footshock.
    Feigley DA, Beakey W, Saynisch MJ.
    Pharmacol Biochem Behav; 1976 Mar; 4(3):255-8. PubMed ID: 935197
    [Abstract] [Full Text] [Related]

  • 7. Changes in sensitivity to operant effects of dopaminergic and cholinergic agents following morphine withdrawal in rats.
    Glick SD, Cox RD.
    Eur J Pharmacol; 1977 Apr 07; 42(3):303-6. PubMed ID: 558097
    [Abstract] [Full Text] [Related]

  • 8. Pilocarpine: noradrenergic mechanism of a cholinergic drug.
    Mason ST.
    Neuropharmacology; 1978 Dec 07; 17(12):1015-21. PubMed ID: 570647
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Scopolamine self-administration: cholinergic involvement in reward mechanisms.
    Glick SD, Guido RA.
    Life Sci; 1982 Aug 30; 31(9):909-13. PubMed ID: 7176819
    [Abstract] [Full Text] [Related]

  • 14. Effects of physostigmine, atropine and scopolamine on behavior maintained by a multiple schedule of food presentation in the mouse.
    Wenger GR.
    J Pharmacol Exp Ther; 1979 Apr 30; 209(1):137-43. PubMed ID: 430373
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The effect of scopolamine on the amnesia induced by electroconvulsive shock.
    Albert DJ, mah CJ, Bose WB.
    Pharmacol Biochem Behav; 1974 May 30; 2(3):443-6. PubMed ID: 4858182
    [No Abstract] [Full Text] [Related]

  • 17. Repeated scopolamine injections sensitize rats to pilocarpine-induced vacuous jaw movements and enhance striatal muscarinic receptor binding.
    Baskin PP, Gianutsos G, Salamone JD.
    Pharmacol Biochem Behav; 1994 Oct 30; 49(2):437-42. PubMed ID: 7824562
    [Abstract] [Full Text] [Related]

  • 18. Interactions of scopolamine and physostigmine with ECS and one trial learning.
    Davis JW, Thomas RK, Adams HE.
    Physiol Behav; 1971 Mar 30; 6(3):219-22. PubMed ID: 5125477
    [No Abstract] [Full Text] [Related]

  • 19. Effects of intrastriatal injections of scopolamine on appetitive behavior.
    Neill DB, Grossman SP.
    Pharmacol Biochem Behav; 1973 Mar 30; 1(3):313-8. PubMed ID: 4590740
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.